117 related articles for article (PubMed ID: 25038134)
1. High Factor VIII and Von Willebrand Factor Levels Are Not Risk Factors of Cryptogenic Arterial Ischemic Stroke in Thai Children.
Sirachainan N; Boonyatarp M; Kadegasem P; Sasanakul W; Visudtibhan A; Natesirinilkul R; Chuansumrit A; Wongwerawattanakoon P
J Child Neurol; 2015 Jul; 30(8):1057-9. PubMed ID: 25038134
[TBL] [Abstract][Full Text] [Related]
2. Relationship of Von Willebrand Factor with carotid artery and aortic arch calcification in ischemic stroke patients.
Sonneveld MA; van Dijk AC; van den Herik EG; van Loon JE; de Lau LM; van der Lugt A; Koudstaal PJ; de Maat MP; Leebeek FW
Atherosclerosis; 2013 Oct; 230(2):210-5. PubMed ID: 24075746
[TBL] [Abstract][Full Text] [Related]
3. Factoring in Factor VIII With Acute Ischemic Stroke.
Siegler JE; Samai A; Albright KC; Boehme AK; Martin-Schild S
Clin Appl Thromb Hemost; 2015 Oct; 21(7):597-602. PubMed ID: 25669199
[TBL] [Abstract][Full Text] [Related]
4. Role of von Willebrand factor in vascular disease.
Paulinska P; Spiel A; Jilma B
Hamostaseologie; 2009 Jan; 29(1):32-8. PubMed ID: 19151843
[TBL] [Abstract][Full Text] [Related]
5. Von Willebrand Factor and Factor VIII levels in Egyptian children with newly diagnosed acute lymphoblastic leukemia in relation to peripheral blast cells and steroid therapy.
El Sherif NH; Narouz MF; Elkerdany TA; El Habashy SA
J Pediatr Hematol Oncol; 2014 Oct; 36(7):518-23. PubMed ID: 25105915
[TBL] [Abstract][Full Text] [Related]
6. Immune tolerance induction with highly purified plasma-derived factor VIII containing von Willebrand factor in hemophilia A patients with high-responding inhibitors.
Orsini F; Rotschild C; Beurrier P; Faradji A; Goudemand J; Polack B
Haematologica; 2005 Sep; 90(9):1288-90. PubMed ID: 16154861
[TBL] [Abstract][Full Text] [Related]
7. [High plasma levels of factor VIII and von Willebrand factor in a patient with portal vein thrombosis].
Günther R; Fölsch UR
Z Gastroenterol; 2002 Jun; 40(6):409-12. PubMed ID: 12055664
[TBL] [Abstract][Full Text] [Related]
8. [Increased von Willebrand activity of low molecular-weight factor VIII following binding to gold granules].
Furlan M; Perret BA; Beck EA
Schweiz Med Wochenschr; 1980 Oct; 110(40):1456-8. PubMed ID: 6792697
[TBL] [Abstract][Full Text] [Related]
9. Identification of a His54Gln substitution in von Willebrand factor from a patient with defective binding of factor VIII.
Rick ME; Krizek DM
Am J Hematol; 1996 Apr; 51(4):302-6. PubMed ID: 8602631
[TBL] [Abstract][Full Text] [Related]
10. Factor VIII/von Willebrand factor in glomerular nephropathies.
Coppola R; Guerra L; Ruggeri ZM; Tarantino A; Mannucci PM; Ponticelli C
Clin Nephrol; 1981 Nov; 16(5):217-22. PubMed ID: 6796318
[TBL] [Abstract][Full Text] [Related]
11. Changes in the levels of factor VIII and von Willebrand factor in the puerperium.
Huq FY; Kulkarni A; Agbim EC; Riddell A; Tuddenham E; Kadir RA
Haemophilia; 2012 Mar; 18(2):241-5. PubMed ID: 21951573
[TBL] [Abstract][Full Text] [Related]
12. Factor VIII binding assay of von Willebrand factor and the diagnosis of type 2N von Willebrand disease--results of an international survey. On behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTH.
Mazurier C; Meyer D
Thromb Haemost; 1996 Aug; 76(2):270-4. PubMed ID: 8865544
[No Abstract] [Full Text] [Related]
13. [Molecular markers of endothelial dysfunction in acute ischemic stroke].
Szegedi N; May Z; Ováry C; Skopál J; Nagy Z
Ideggyogy Sz; 2002 Mar; 55(3-4):102-8. PubMed ID: 12122979
[TBL] [Abstract][Full Text] [Related]
14. Impact of factor VIII and von Willebrand factor plasma levels on cerebral venous and sinus thrombosis: are they independent risk factors?
Shahsavarzadeh T; Javanmard SH; Saadatnia M
Eur Neurol; 2011; 66(4):243-6. PubMed ID: 21967990
[TBL] [Abstract][Full Text] [Related]
15. von Willebrand factor/factor VIII binding is not affected by the Arg89Gln polymorphism in von Willebrand factor.
Nesbitt IM; Goodeve AC; Preston FE; Peake IR
Thromb Haemost; 1996 Nov; 76(5):820-1. PubMed ID: 8950801
[No Abstract] [Full Text] [Related]
16. Role of hemostatic factors on the risk of venous thrombosis in people with impaired kidney function.
Ocak G; Vossen CY; Lijfering WM; Verduijn M; Dekker FW; Rosendaal FR; Cannegieter SC
Circulation; 2014 Feb; 129(6):683-91. PubMed ID: 24211824
[TBL] [Abstract][Full Text] [Related]
17. Influence of factor VIII/von Willebrand complex on the activated protein C-resistance phenotype and on the risk for venous thromboembolism in heterozygous carriers of the factor V Leiden mutation.
De Mitrio V; Marino R; Scaraggi FA; Di Bari L; Giannoccaro F; Petronelli M; Ranieri P; Tannoia N; Schiraldi O
Blood Coagul Fibrinolysis; 1999 Oct; 10(7):409-16. PubMed ID: 10695766
[TBL] [Abstract][Full Text] [Related]
18. The spectrum of von Willebrand's disease revisited.
Bowie EJ; Fass DN; Olson JD; Owen CA
Mayo Clin Proc; 1976 Jan; 51(1):35-41. PubMed ID: 765637
[TBL] [Abstract][Full Text] [Related]
19. von Willebrand factor binds to the surface of dendritic cells and modulates peptide presentation of factor VIII.
Sorvillo N; Hartholt RB; Bloem E; Sedek M; ten Brinke A; van der Zwaan C; van Alphen FP; Meijer AB; Voorberg J
Haematologica; 2016 Mar; 101(3):309-18. PubMed ID: 26635035
[TBL] [Abstract][Full Text] [Related]
20. [Importance of the study of the binding of factor VIII to von Willebrand factor in hemophilia A].
Batlle J; Blanco-López MJ; Castiñeira MP; López-Fernández MF
Sangre (Barc); 1992 Jun; 37(3):211-24. PubMed ID: 1359656
[No Abstract] [Full Text] [Related]
[Next] [New Search]